Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol in clinical practice: ANMCO position paper

被引：14

作者：

Colivicchi, Furio ^{[1
]}

Di Fusco, Stefania Angela ^{[1
]}

Arca, Marcello ^{[2
]}

Leggio, Massimo ^{[1
]}

Caldarola, Pasquale ^{[3
]}

Murrone, Adriano ^{[4
]}

Valente, Serafina ^{[5
]}

Urbinati, Stefano ^{[6
]}

Roncon, Loris ^{[7
]}

Amodeo, Vincenzo ^{[8
]}

Aspromonte, Nadia ^{[9
]}

Cipriani, Manlio ^{[10
]}

Domenicucci, Stefano ^{[11
]}

Francese, Giuseppina Maura ^{[12
]}

Imazio, Massimo ^{[13
]}

di Uccio, Fortunato Scotto ^{[14
]}

Di Lenarda, Andrea ^{[15
]}

Gulizia, Michele Massimo ^{[12
,16
]}

Gabrielli, Domenico ^{[17
]}

机构：

[1] San Filippo Neri Hosp ASL Roma 1, Clin & Rehabilitat Cardiol Unit, Rome, Italy

[2] Sapienza Univ Roma, Dept Translat & Precis Med, Rome, Italy

[3] San Paolo Hosp, UOC Cardiol UTIC, Bari, Italy

[4] Osped Citta Castello & Gubbio Gualdo Tadino, Cardil Intens Care Unit, Azienda USL Umbria 1, Perugia, Italy

[5] Le Scotte Univ Hosp, Cardiol Dept, Siena, Italy

[6] AUSL Bologna, Bellaria Hosp, Cardiol Unit, Bologna, Italy

[7] Osped Santa Maria Misericordia, Cardiol Unit, Rovigo, Italy

[8] Santa Maria Ungheresi Hosp, Cardil Intens Care Unit, Reggio Di Calabria, Italy

[9] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc & Thorac Sci, Rome, Italy

[10] ASST Grande Osped Metropolitano Niguarda Ca Grand, Cardiol Unit 2, Milan, Italy

[11] Osped Padre A Micone, ASL 3, Cardiol Unit, Genoa, Italy

[12] Osped Garibaldi Nesima, Azienda Rilievo Nazl & Alta Specializzaz Garibald, Cardiol Div, Catania, Italy

[13] AOU Citta Salute & Sci Torino, Presidio Molinette, Cardil Unit, Turin, Italy

[14] Osped Mare Napoli, Cardiol UTIC Emodinam, Naples, Italy

[15] Univ Hosp & Hlth Serv Trieste, Cardiovasc Ctr, Trieste, Italy

[16] Heart Care Fdn, Fdn Tuo Cuore, Florence, Italy

[17] Augusto Murri Hosp, Div Cardiol, Fermo, Italy

来源：

JOURNAL OF CARDIOVASCULAR MEDICINE | 2021年 / 22卷 / 08期

关键词：

cardiovascular risk; cholesterol; low-density lipoprotein cholesterol; non-high-density lipoprotein cholesterol; therapeutic target; NON-HDL CHOLESTEROL; CORONARY-HEART-DISEASE; APOLIPOPROTEIN-B; LDL-CHOLESTEROL; CARDIOVASCULAR-DISEASE; REDUCING LIPIDS; RISK; METAANALYSIS; EFFICACY; SAFETY;

D O I：

10.2459/JCM.0000000000001175

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Bloodstream cholesterol is a central contributor to atherosclerotic cardiovascular diseases. For several decades, low-density lipoprotein cholesterol (LDL-C) has been the main biomarker for the prediction of cardiovascular events and therapeutic target of lipid-lowering treatments. More recently, several findings have supported the greater reliability of non-high-density lipoprotein cholesterol (non-HDL-C) as a predictive factor and possible therapeutic target in refining antiatherogenic treatments, especially among patients with lower LDL-C and higher triglyceride values. This article discusses the limits of current standard methods for assessing LDL-C levels and emphasizes the persistent residual cardiovascular risk in patients treated with lipid-lowering agents on the basis of recommended LDL-C targets. It highlights that patients with controlled LDL-C and non-targeted non-HDL-C have a higher cardiovascular risk. The article focuses on the role of non-HDL-C as a better predictor of atherosclerotic disease as compared with LDL-C and as a therapeutic target. Finally, this article includes an executive summary aimed at refining preventive approaches in atherosclerotic cardiovascular disease.

引用

页码：609 / 617

页数：9

共 66 条

[1] Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper Center Longitudinal Study [J].

Abdullah, Shuaib M. ;

Defina, Laura F. ;

Leonard, David ;

Barlow, Carolyn E. ;

Radford, Nina B. ;

Willis, Benjamin L. ;

Rohatgi, Anand ;

McGuire, Darren K. ;

de Lemos, James A. ;

Grundy, Scott M. ;

Berry, Jarett D. ;

Khera, Amit .

CIRCULATION, 2018, 138 (21) :2315-2325

[2]

[Anonymous], NICE CLIN GUID

[3] 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) [J].

Catapano, Alberico L. ;

Graham, Ian ;

De Backer, Guy ;

Wiklund, Olov ;

Chapman, M. John ;

Drexel, Heinz ;

Hoes, Arno W. ;

Jennings, Catriona S. ;

Landmesser, Ulf ;

Pedersen, Terje R. ;

Reiner, Zeljko ;

Riccardi, Gabriele ;

Taskinen, Marja-Riita ;

Tokgozoglu, Lale ;

Verschuren, W. M. Monique ;

Vlachopoulos, Charalambos ;

Wood, David A. ;

Luis Zamorano, Jose .

ATHEROSCLEROSIS, 2016, 253 :281-344

[4] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].

Baigent, C ;

Keech, A ;

Kearney, PM ;

Blackwell, L ;

Buck, G ;

Pollicino, C ;

Kirby, A ;

Sourjina, T ;

Peto, R ;

Collins, R ;

Simes, J .

LANCET, 2005, 366 (9493) :1267-1278

[5] Alirocumab Treatment and Achievement of Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials [J].

Bays, Harold E. ;

Leiter, Lawrence A. ;

Colhoun, Helen M. ;

Thompson, Desmond ;

Bessac, Laurence ;

Pordy, Robert ;

Toth, Peter P. .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (08)

[6] Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia [J].

Bhatt, Deepak L. ;

Steg, P. Gabriel ;

Miller, Michael ;

Brinton, Eliot A. ;

Jacobson, Terry A. ;

Ketchum, Steven B. ;

Doyle, Ralph T., Jr. ;

Juliano, Rebecca A. ;

Jiao, Lixia ;

Granowitz, Craig ;

Tardif, Jean-Claude ;

Ballantyne, Christie M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01) :11-22

[7] PREDICTION OF ANGIOGRAPHIC CHANGE IN NATIVE HUMAN CORONARY-ARTERIES AND AORTOCORONARY BYPASS GRAFTS - LIPID AND NONLIPID FACTORS [J].

BLANKENHORN, DH ;

ALAUPOVIC, P ;

WICKHAM, E ;

CHIN, HP ;

AZEN, SP .

CIRCULATION, 1990, 81 (02) :470-476

[8] Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics [J].

Boden, William E. ;

Bhatt, Deepak L. ;

Toth, Peter P. ;

Ray, Kausik K. ;

Chapman, M. John ;

Luescher, Thomas F. .

EUROPEAN HEART JOURNAL, 2020, 41 (24) :2304-+

[9] Association of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins A Meta-analysis [J].

Boekholdt, S. Matthijs ;

Arsenault, Benoit J. ;

Mora, Samia ;

Pedersen, Terje R. ;

LaRosa, John C. ;

Nestel, Paul J. ;

Simes, R. John ;

Durrington, Paul ;

Hitman, Graham A. ;

Welch, K. M. A. ;

DeMicco, David A. ;

Zwinderman, Aeilko H. ;

Clearfield, Michael B. ;

Downs, John R. ;

Tonkin, Andrew M. ;

Colhoun, Helen M. ;

Gotto, Antonio M., Jr. ;

Ridker, Paul M. ;

Kastelein, John J. P. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (12) :1302-1309

[10] Apolipoprotein B and Non-High-Density Lipoprotein Cholesterol Are Better Risk Markers for Coronary Artery Disease than Low-Density Lipoprotein Cholesterol in Hypertriglyceridemic Metabolic Syndrome Patients [J].

Boumaiza, Imen ;

Omezzine, Asma ;

Rejeb, Jihene ;

Rebhi, Lamia ;

Kalboussi, Nesrine ;

Ben Rejeb, Nabila ;

Nabli, Naoufel ;

Ben Abdelaziz, Ahmed ;

Boughazala, Essia ;

Bouslama, Ali .

METABOLIC SYNDROME AND RELATED DISORDERS, 2010, 8 (06) :515-522

← 1 2 3 4 5 6 7 →